UBS raised the firm’s price target on Exelon (EXC) to $50 from $48 and keeps a Neutral rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXC:
- Exelon: Strong Regulatory Environment and Growth Prospects Justify Buy Rating
- Exelon initiated with an Outperform at Evercore ISI
- Exelon: Strategic Growth and Attractive Risk-Return Profile Amidst Regulatory Clarity
- Exelon price target lowered to $49 from $50 at Morgan Stanley
- Sunrun, BGE activated first residential vehicle-to-grid power plant